Rheumatoid arthritis drug falls short as treatment for hospitalized COVID-19 patients in three studies

  • By cvbizz
  • October 22, 2020
  • 0

via wyff.com

Share This Post!

Related video above: Doctor explains: Effectiveness of COVID treatments, prevention measuresTocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with COVID-19, generally did not increase patients’ chances of survival or help them get better faster, according to three trials published this week.However, a fourth trial did find the drug increased the chances of survival, but because it was an observational

..... Read full article

Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com